Effect of dietary enrichment with n-3 polyunsaturated fatty acids (PUFA) or n-9 PUFA on arachidonate metabolism in vivo and experimentally induced inflammation in mice

Biological and Pharmaceutical Bulletin

Volumn 27, Issue 3, 2004, Pages 319-323

  Doshi, Masaru ^a   Watanabe, Shiro ^a   Niimoto, Tsuyoshi ^a   Kawashima, Hiroshi ^b   Ishikura, Yoshiyuki ^b   Kiso, Yoshinobu ^b   Hamazaki, Tomohito ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

^b SUNTORY LTD   (Japan)

Author keywords

Docosahexaenoic acid; Eicosatrienoic acid; Granuloma; Leukotriene air pouch inflammation; Prostaglandin

Indexed keywords

ARACHIDONATE 5 LIPOXYGENASE; ARACHIDONIC ACID; FREUND ADJUVANT; GALACTOSAMINE; LEUKOTRIENE; LIPOPOLYSACCHARIDE; OMEGA 3 FATTY ACID; PROSTAGLANDIN; PROSTAGLANDIN SYNTHASE; FISH OIL; LIPID; PROSTAGLANDIN SYNTHASE INHIBITOR; TRIACYLGLYCEROL; UNSATURATED FATTY ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARACHIDONIC ACID METABOLISM; ARTICLE; CONTROLLED STUDY; DIET; DIET SUPPLEMENTATION; FEMALE; GRANULOMA; IN VIVO STUDY; INFLAMMATION; LEUKOCYTE; LIVER INJURY; MALE; MOUSE; NONHUMAN; ACUTE DISEASE; ANIMAL; BAGG ALBINO MOUSE; CHEMISTRY; COMPARATIVE STUDY; CYTOLOGY; DRUG ANTAGONISM; ENZYMOLOGY; LEUKOCYTE COUNT; LIVER DISEASE; METABOLISM; PERITONEAL CAVITY;

ACUTE DISEASE; ANIMALS; ARACHIDONATE 5-LIPOXYGENASE; ARACHIDONIC ACID; CYCLOOXYGENASE INHIBITORS; DIET; FATTY ACIDS, OMEGA-3; FATTY ACIDS, UNSATURATED; FEMALE; FREUND'S ADJUVANT; GALACTOSAMINE; GRANULOMA; INFLAMMATION; LEUKOCYTE COUNT; LIPIDS; LIPOPOLYSACCHARIDES; LIVER DISEASES; MALE; MICE; MICE, INBRED BALB C; PERITONEAL CAVITY; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; TRIGLYCERIDES;

EID: 16544374721     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.27.319     Document Type: Article

References (29)

1. Oh-hashi K., Takahashi T., Watanabe S., Kobayashi T., Okuyama H., Hata N., Misawa Y., Biol. Pharm. Bull., 21, 558-564 (1998).
2. Watanabe S., Katagiri K., Onozaki K., Hata N., Misawa Y., Hamazaki T., Okuyama H., Prostagl. Leukotr. Essent. Fatty Acids, 62, 147-152 (2000).
3. Stenson W. F., Prescott S. M., Sprecher H., J. Biol. Chem., 259, 11784-11789 (1984).
4. Schreiner G. F., Rovin B., Lefkowith J. B., J. Immunol., 143, 3192-3199 (1989).
5. James M. J., Gibson R. A., Neumann M. A., Cleland L. G., J. Exp. Med., 178, 2261-2265 (1993).
6. Cleland L. G., Gibson R. A., Neumann M. A., Hamazaki T., Akimoto K., James M. J., J. Nutr., 126, 1534-1540 (1996).
7. Watanabe S., Doshi M., Akimoto K., Kiso Y., Hamazaki T., Prostaglandins Other Lipid Mediat., 66, 109-120 (2001).
8. Jareonkitmongkol S., Kawashima H., Shimizu S., Yamada H., J. Am. Oil Chem. Soc., 69, 939-944 (1992).
9. Kawashima H., Nishihara M., Hirano Y., Kamada N., Akimoto K., Konishi K., Shimizu S., Appl. Environ. Microbiol., 63, 1820-1825 (1997).
10. Posadas I., Terencio M. C., Guilltén I., Ferrándiz M. L., Payá M., Alcaraz M. J., Naunyn-Schmiedeberg's Arch. Pharmacol., 361, 98-106 (2000).
11. William S. P., "Prostaglandins and Related Substances: A Practical Approach," ed. by Benedetto C., McDonald-Gibson R. G., Nigam S., Slater T. F., IRL Press, Oxford, 1987, pp. 75-98.
12. Jackson J. R., Bolognese B., Mangar C. A., Hubbard W. C., Marshall L. A., Winkler J. D., Biochim. Biophys. Acta, 1392, 145-152 (1998).
13. Bligh E. G., Dyer W. J., Can. J. Biochem. Physiol., 37, 911-917 (1959).
14. Hwang D. H., Boudreau M., Chanmugam P., J. Nutr., 118, 427-437 (1988).
15. Evans J. F., Nathaniel D. J., Zamboni R. J., Ford-Hutchinson A. W., J. Biol. Chem., 260, 10966-10970 (1985).
16. Yoshimoto T., Soberman R. J., Spur B., Austen K. F., J. Clin. Invest., 81, 866-871 (1988).
17. Oliw E. H., Hörnsten L., Sprecher H., J. Chromatogr. B, 690, 332-337 (1997).
18. Henderson W. R., Jr., Ann. Intern. Med., 121, 684-697 (1994).
19. Byrum R. S., Goulet J. L., Snouwaert J. N., Griffiths R. J., Koller B. H., J. Immunol., 163, 6810-6819 (1999).
20. Kimura M., Suzuki J., Amemiya K., J. Pharmacobio-Dyn., 8, 393-400 (1985).
21. Gilroy D. W., Tomlinson A., Willoughby D. A., Inflamm. Res., 47, 79-85 (1998).
22. Wendel A., Tiegs G., Biochem. Pharmacol., 35, 2115-2118 (1986).
23. Keppler D., Hagmann W., Rapp S., Denzlinger C., Koch H. K., Hepatology, 5, 883-891 (1985).
24. Lehmann V., Freudenberg M. A., Galanos C., J. Exp. Med., 165, 657-663 (1987).
25. Tiegs G., Wolter M., Wendel A., Biochem. Pharmacol., 38, 627-631 (1989).
26. Pfeffer K., Matsuyama T., Kündig T. M., Wakeham A., Kishiara K., Shahinian A., Wiegmann K., Ohashi P. S., Krönke M., Mak T. W., Cell, 73, 457-467 (1993).
27. Schlayer H. J., Laaff H., Peters T., Woort-Menker M., Estler H. C., Karck U., Schaefer H. E., Decker K., J. Hepatol., 7, 239-249 (1988).
28. Kunkel S. L., Wiggins R. C., Chensue S. W., Larrick J., Remick D., Biochem. Biophys. Res. Commun., 137, 404-410 (1988).
29. Watanabe S., Okuyama H., Lipids, 26, 467-471 (1991).